CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
| Operating expenses: | ||
| Research and development | $ 27,677 | $ 36,186 |
| General and administrative | 13,240 | 12,664 |
| Total operating expenses | 40,917 | 48,850 |
| Loss from operations | (40,917) | (48,850) |
| Other income (expense): | ||
| Interest income | 26 | 1,049 |
| Interest expense | (1,748) | (985) |
| Other income, net | 309 | 300 |
| Total other income (expense), net | (1,413) | 364 |
| Net loss | $ (42,330) | $ (48,486) |
| Net loss per share, basic and diluted | $ (0.51) | $ (0.60) |
| Weighted average common shares outstanding, basic and diluted | 82,314,577 | 80,271,848 |
| Comprehensive loss: | ||
| Net loss | $ (42,330) | $ (48,486) |
| Other comprehensive income (loss): | ||
| Unrealized gains on investments, net of tax of $0 | 3 | 456 |
| Comprehensive loss | $ (42,327) | $ (48,030) |